{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:02:17Z","timestamp":1791540137406,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejso.2018.08.020","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T12:40:10Z","timestamp":1536324010000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer \u2013 A systematic review"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-3848","authenticated-orcid":false,"given":"Abdul R","family":"Hakeem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Papoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna V","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejso.2018.08.020_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1479-666X(08)80073-X","article-title":"Gallbladder cancer--a comprehensive review","volume":"6","author":"Lai","year":"2008","journal-title":"Surgeon"},{"issue":"3","key":"10.1016\/j.ejso.2018.08.020_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","article-title":"Carcinoma of the gallbladder","volume":"4","author":"Misra","year":"2003","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2018.08.020_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","article-title":"Current management of gallbladder carcinoma","volume":"15","author":"Zhu","year":"2010","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.ejso.2018.08.020_bib4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/hpb.12444","article-title":"Gallbladder cancer: expert consensus statement","volume":"17","author":"Aloia","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"7","key":"10.1016\/j.ejso.2018.08.020_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/000313481708300721","article-title":"Pathologic and prognostic implications of incidental","volume":"83","author":"Ethun","year":"2017","journal-title":"Am Surg"},{"issue":"14","key":"10.1016\/j.ejso.2018.08.020_bib6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ejso.2018.08.020_bib7","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s11605-012-1935-1","article-title":"Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins","volume":"16","author":"Glazer","year":"2012","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.ejso.2018.08.020_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.surg.2013.04.022","article-title":"Aggressive surgical management of gallbladder cancer: at what cost?","volume":"154","author":"Jin","year":"2013","journal-title":"Surgery (St Louis)"},{"issue":"2","key":"10.1016\/j.ejso.2018.08.020_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11912-018-0664-3","article-title":"Updates on gallbladder cancer management","volume":"20","author":"Zaidi","year":"2018","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"10.1016\/j.ejso.2018.08.020_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/13651820802029427","article-title":"The role of chemotherapy in biliary tract carcinoma","volume":"10","author":"Verslype","year":"2008","journal-title":"HPB (Oxford)"},{"issue":"16","key":"10.1016\/j.ejso.2018.08.020_bib11","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2018.08.020_bib12","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2018.08.020_bib13","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.4006","article-title":"Adjuvant capecitabine for biliary tract cancer: the BILCAP randomized study","volume":"35","author":"Primrose","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.08.020_bib14","first-page":"CD011746","article-title":"Gemcitabine-based chemotherapy for advanced biliary tract carcinomas","volume":"4","author":"Abdel-Rahman","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ejso.2018.08.020_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12029-017-0036-5","article-title":"Staging, treatment, and future approaches of gallbladder carcinoma","volume":"49","author":"Shukla","year":"2018","journal-title":"J\u00a0Gastrointest Canc"},{"issue":"9","key":"10.1016\/j.ejso.2018.08.020_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.hpb.2018.03.008","article-title":"Outcome of neoadjuvant chemotherapy in \"locally advanced\/borderline resectable\" gallbladder cancer: the need to define indications","volume":"20","author":"Chaudhari","year":"2018","journal-title":"HPB (Oxford)"},{"issue":"5","key":"10.1016\/j.ejso.2018.08.020_bib17","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jamcollsurg.2016.12.058","article-title":"Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes","volume":"224","author":"Creasy","year":"2017","journal-title":"J\u00a0Am Coll Surg"},{"issue":"9","key":"10.1016\/j.ejso.2018.08.020_bib18","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1245\/s10434-016-5197-0","article-title":"Neoadjuvant chemoradiation followed by surgery for locally advanced gallbladder cancers: a new paradigm","volume":"23","author":"Engineer","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2018.08.020_bib19","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.7314\/APJCP.2016.17.4.2137","article-title":"Radiological downstaging with neoadjuvant therapy in unresectable gall bladder cancer cases","volume":"17","author":"Agrawal","year":"2016","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"3","key":"10.1016\/j.ejso.2018.08.020_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12029-015-9742-z","article-title":"Reduced dose intensity of chemotherapy may not lead to inferior palliation in locally advanced carcinoma of the gall bladder: an experience from a regional cancer centre in eastern India","volume":"46","author":"Gangopadhyay","year":"2015","journal-title":"J\u00a0Gastrointest Canc"},{"issue":"1","key":"10.1016\/j.ejso.2018.08.020_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13193-015-0377-0","article-title":"Resection after neoadjuvant chemotherapy in advanced carcinoma of the gallbladder: a retrospective study","volume":"6","author":"Selvakumar","year":"2015","journal-title":"Indian J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2018.08.020_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1245\/s10434-012-2312-8","article-title":"Urgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study","volume":"20","author":"Kato","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2018.08.020_bib23","first-page":"51","article-title":"Neoadjuvant chemoradiotherapy in gallbladder cancer","volume":"132","author":"de Aretxabala","year":"2004","journal-title":"Rev Med Chile"},{"issue":"15","key":"10.1016\/j.ejso.2018.08.020_bib24","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"J\u00a0Am Med Assoc"},{"issue":"7306","key":"10.1016\/j.ejso.2018.08.020_bib25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/bmj.323.7306.224","article-title":"Systematic reviews of evaluations of prognostic variables","volume":"323","author":"Altman","year":"2001","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ejso.2018.08.020_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.ejso.2018.08.020_bib27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jjco\/hyg093","article-title":"Measuring response in solid tumors: comparison of RECIST and WHO response criteria","volume":"33","author":"Park","year":"2003","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2018.08.020_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4143\/crt.2005.37.5.290","article-title":"Comparison of WHO and RECIST criteria for response in metastatic colorectal carcinoma","volume":"37","author":"Choi","year":"2005","journal-title":"Cancer Res Treat"},{"issue":"7454","key":"10.1016\/j.ejso.2018.08.020_bib29","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ejso.2018.08.020_bib30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jso.24837","article-title":"Emerging role of multimodality treatment in gall bladder cancer: outcomes following 510 consecutive resections in a tertiary referral center","volume":"117","author":"Patkar","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2018.08.020_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00280-017-3353-2","article-title":"Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients","volume":"80","author":"Kim","year":"2017","journal-title":"Canc Chemother Pharmacol"},{"issue":"10","key":"10.1016\/j.ejso.2018.08.020_bib32","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2217\/fon.14.308","article-title":"Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer","volume":"11","author":"Sirohi","year":"2015","journal-title":"Future Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2018.08.020_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/000313489906500312","article-title":"Preoperative chemoradiotherapy in the treatment of gallbladder cancer","volume":"65","author":"de Aretxabala","year":"1999","journal-title":"Am Surg"},{"key":"10.1016\/j.ejso.2018.08.020_bib34","unstructured":"Oxford centre for Evidence-based Medicine \u2013 Levels of Evidence. http:\/\/www.cebm.net [accessed 20 May 2018]."},{"issue":"4","key":"10.1016\/j.ejso.2018.08.020_bib35","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","article-title":"8th edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers","volume":"25","author":"Chun","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2018.08.020_bib36","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/MOG.0000000000000068","article-title":"Aspects on gallbladder cancer in 2014","volume":"30","author":"\u00c5ndr\u00e9n-Sandberg","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejso.2018.08.020_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.6004\/jnccn.2017.7067","article-title":"Chemoradiotherapy versus chemotherapy alone for unresected nonmetastatic gallbladder cancer: national practice patterns and outcomes","volume":"16","author":"Verma","year":"2018","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"8","key":"10.1016\/j.ejso.2018.08.020_bib38","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/hpb.12432","article-title":"Consensus conference on gallbladder cancer","volume":"17","author":"Shroff","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"9","key":"10.1016\/j.ejso.2018.08.020_bib39","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1245\/s10434-016-5262-8","article-title":"Impact of chemotherapy and external-beam radiation therapy on outcomes among patients with resected gallbladder cancer: a multi-institutional analysis","volume":"23","author":"Kim","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2018.08.020_bib40","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12885-015-1617-y","article-title":"Adjuvant therapy in the treatment of gallbladder cancer: a meta-analysis","volume":"15","author":"Ma","year":"2015","journal-title":"BMC Canc"},{"issue":"19","key":"10.1016\/j.ejso.2018.08.020_bib41","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2018.08.020_bib42","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind CH. TNM classification of malignant tumors (UICC International Union Against Cancer). http:\/\/www.inen.sld.pe\/portal\/documentos\/pdf\/educacion\/13072015_TNM%20Classification.pdf. [accessed 20 May 2018]."},{"issue":"3","key":"10.1016\/j.ejso.2018.08.020_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jhbp.211","article-title":"Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition","volume":"22","author":"Miyazaki","year":"2015","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"2","key":"10.1016\/j.ejso.2018.08.020_bib44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00534-009-0044-3","article-title":"Hepatic resection in 485 R0 pT2 and pT3 cases of advanced carcinoma of the gallbladder: results of a Japanese Society of Biliary Surgery survey--a multicenter study","volume":"16","author":"Araida","year":"2009","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"issue":"3","key":"10.1016\/j.ejso.2018.08.020_bib45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1245\/ASO.2004.03.011","article-title":"Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer","volume":"11","author":"Hawkins","year":"2004","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2018.08.020_bib46","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/jso.24797","article-title":"Decision of surgical approach for advanced gallbladder adenocarcinoma based on a Bayesian network","volume":"116","author":"Cong","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2018.08.020_bib47","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1245\/s10434-014-3885-1","article-title":"Surgical approaches to advanced gallbladder cancer: a 40-year single-institution study of prognostic factors and resectability","volume":"21","author":"Higuchi","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2018.08.020_bib48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.sla.0000154118.07704.ef","article-title":"An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center","volume":"241","author":"Dixon","year":"2005","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.ejso.2018.08.020_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166361","article-title":"Long-term outcomes and prognostic factors in advanced gallbladder cancer: focus on the advanced T stage","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"issue":"suppl 5","key":"10.1016\/j.ejso.2018.08.020_bib50","doi-asserted-by":"crossref","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","article-title":"ESMO guidelines committee. Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Valle","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2018.08.020_bib51","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ajg.2014.363","article-title":"Awareness of tract seeding with endoscopic ultrasound tissue acquisition in perihilar cholangiocarcinoma","volume":"110","author":"Razumilava","year":"2015","journal-title":"Am J Gastroenterol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318312952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318312952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:30:39Z","timestamp":1760059839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798318312952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0748798318312952"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2018.08.020","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer \u2013 A systematic review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2018.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}